The goal of Applied Genomics is to develop a novel set of tools useful for the detection and classification of human cancer.  We are accomplishing this by developing a process  whereby complex gene expression data is used to nominate antibodies for production and direct the analysis of the protein distribution across thousands of tumor tissues.  AGI is thereby able to identify antibodies that can act as biomarkers which define a much more sophisticated and detailed classification of cancer than is currently available.

Applied Genomics initially began from a collaboration between Stanford and Research Genetics located in Huntsville, AL (now a subsidiary of Invitrogen, Inc.). AGI was founded in 2000 by Robert Seitz, CEO of AGI and previous founder and Director of the Antibody Department at Research Genetics, and Doug Ross, MD, PhD, Chief Scientific Officer of AGI and former postdoctoral fellow in Patrick Brown's laboratory at Stanford University.

The company has two facilities: corporate headquarters in Huntsville, AL where the antibodies are produced and a research facility in Sunnyvale, CA.